ES468525A1 - Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas - Google Patents

Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas

Info

Publication number
ES468525A1
ES468525A1 ES468525A ES468525A ES468525A1 ES 468525 A1 ES468525 A1 ES 468525A1 ES 468525 A ES468525 A ES 468525A ES 468525 A ES468525 A ES 468525A ES 468525 A1 ES468525 A1 ES 468525A1
Authority
ES
Spain
Prior art keywords
alkyleneaminodihydropyridines
compounds
production
medicinal use
provision
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES468525A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772715182 external-priority patent/DE2715182A1/de
Priority claimed from DE19772740080 external-priority patent/DE2740080A1/de
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES468525A1 publication Critical patent/ES468525A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procedimiento para la obtención de 2-alquilen- aminodihidropiridinas de fórmula **(Fórmula)** don R1 significa hidrógeno, alquilo, alcoxi-alquilo ó aralquilo, donde los mencionados grupos alquilo y arilo están en caso dado sustituidos, A significa un resto alquileno, de cadena recta o ramificada, Y y Z son iguales o diferentes y significan a) una agrupación COOR2 ó COR2. b) un resto ciano o c) un resto SO(n)-R3- n representa 0, 1 ó 2, R4 significa hidrógeno o alquilo X significa un resto arilo.
ES468525A 1977-04-05 1978-04-04 Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas Expired ES468525A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772715182 DE2715182A1 (de) 1977-04-05 1977-04-05 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE19772740080 DE2740080A1 (de) 1977-09-06 1977-09-06 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ES468525A1 true ES468525A1 (es) 1979-07-01

Family

ID=25771839

Family Applications (1)

Application Number Title Priority Date Filing Date
ES468525A Expired ES468525A1 (es) 1977-04-05 1978-04-04 Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas

Country Status (8)

Country Link
US (1) US4177278A (es)
JP (1) JPS53124274A (es)
AT (1) AT361478B (es)
ES (1) ES468525A1 (es)
FR (1) FR2386527A1 (es)
GB (1) GB1585978A (es)
IL (1) IL54429A (es)
NL (1) NL7803626A (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
US4365063A (en) * 1981-08-31 1982-12-21 American Home Products Corporation Antihypertensive agents
US4321384A (en) * 1981-02-27 1982-03-23 American Home Products Corporation Antihypertensive agents
CS228917B2 (en) 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
JPS597163A (ja) * 1982-07-02 1984-01-14 Yamanouchi Pharmaceut Co Ltd 抗動脈硬化剤
EP0100189B1 (en) * 1982-07-22 1986-05-28 Pfizer Limited Dihydropyridine anti-ischaemic and antihypertensive agents
EP0107293A3 (en) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridines
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
PT77842B (en) * 1982-12-21 1986-05-05 Pfizer Process for preparing dihydropyridines
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
US4520131A (en) * 1983-03-03 1985-05-28 Usv Pharmaceutical Antihypertensive N-substituted 1,4-dihydropyridines
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法
JPS60214778A (ja) * 1984-03-08 1985-10-28 Suntory Ltd Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途
GR851819B (es) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
IT1215298B (it) * 1985-08-06 1990-01-31 Boehringer Biochemia Srl 2-(eteroalchil)-1,4-diidropiridine ed un processo per la loro produzione.
DE3544211A1 (de) * 1985-12-13 1987-06-19 Bayer Ag Neue, fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
FR2602231B1 (fr) * 1986-08-04 1988-10-28 Adir Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US5234959A (en) * 1988-04-08 1993-08-10 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US5472946A (en) * 1988-04-08 1995-12-05 Peck; James V. Transdermal penetration enhancers
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210674C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Also Published As

Publication number Publication date
IL54429A (en) 1981-07-31
ATA240378A (de) 1980-08-15
NL7803626A (nl) 1978-10-09
FR2386527B1 (es) 1980-07-18
JPS53124274A (en) 1978-10-30
AT361478B (de) 1981-03-10
FR2386527A1 (fr) 1978-11-03
US4177278A (en) 1979-12-04
JPS6126783B2 (es) 1986-06-21
GB1585978A (en) 1981-03-11
IL54429A0 (en) 1978-07-31

Similar Documents

Publication Publication Date Title
ES468525A1 (es) Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ES480351A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas ni- tro-sustituidas.
ES463632A1 (es) Procedimiento de preparacion de derivados de la piperidina.
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
DE3063420D1 (en) Tetrahydroisoquinolines, their production and the compounds and pharmaceutical compositions containing them for use in the prevention or treatment of hypertension
ES475633A1 (es) Procedimiento para la obtencion de derivados de 1-n-4,6-di-0-(aminoglicosil)-1,3-diamino-ciclitol.
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
ES478048A1 (es) Procedimiento para la obtencion de difenil-imidazolil-meta- nos sustituidos.
ES425514A1 (es) Un procedimiento para la preparacion de nuevas 3-nitrocuma-rinas.
SE8405588D0 (sv) New compounds
ES8301244A1 (es) Procedimiento para la obtencion de derivados de sisomicina.
ES479059A1 (es) Procedimiento para preparar derivados del naftaleno.
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ES462387A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridin-azucar.
ES8203334A1 (es) Procedimiento para la obtencion de dehidropeptidos
ES473316A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas.
ATE22282T1 (de) Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
ES8304152A1 (es) Procedimiento para la obtencion de derivzados de aminociclitol.
ES450299A1 (es) Un procedimiento de fabricacion de nuevos compuestos quimi- cos derivados de n-pinolidin-2-etilamina.
BE842528R (fr) Derives actifs de methylamine, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
ATE87314T1 (de) Platin-arzneimittel.

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960604